Tuoxin Pharmaceutical Group Co Ltd Class A 301089
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 34.81
- Day Range
- CNY 34.77–35.68
- 52-Week Range
- CNY 31.35–78.10
- Bid/Ask
- CNY 34.84 / CNY 34.85
- Market Cap
- CNY 4.41 Bil
- Volume/Avg
- 2.0 Mil / 4.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- 18.36
- Price/Sales
- 10.87
- Dividend Yield (Trailing)
- 0.70%
- Dividend Yield (Forward)
- 0.70%
- Total Yield
- 0.72%
Company Profile
Tuoxin Pharmaceutical Group Co Ltd, formerly Xinxiang Tuoxin Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical synthesis and biological fermentation nucleoside APIs and pharmaceutical intermediates.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,491
- Website
- http://www.tuoxinpharm.com
Comparables
Valuation
|
Metric
|
301089
|
600521
|
688091
|
|---|---|---|---|
Price/Earnings (Normalized) | 18.36 | 25.51 | 36.12 |
Price/Book Value | 2.80 | 3.09 | 3.71 |
Price/Sales | 10.87 | 2.88 | 16.97 |
Price/Cash Flow | — | 9.34 | 66.72 |
Price/Earnings
301089
600521
688091
Financial Strength
|
Metric
|
301089
|
600521
|
688091
|
|---|---|---|---|
Quick Ratio | 3.18 | 0.81 | 12.60 |
Current Ratio | 4.56 | 1.33 | 12.93 |
Interest Coverage | −1,600.44 | 6.22 | 275.37 |
Quick Ratio
301089
600521
688091
Profitability
|
Metric
|
301089
|
600521
|
688091
|
|---|---|---|---|
Return on Assets (Normalized) | −3.77% | 5.62% | 9.34% |
Return on Equity (Normalized) | −4.33% | 13.24% | 9.87% |
Return on Invested Capital (Normalized) | −4.49% | 7.70% | 8.12% |
Return on Assets
301089
600521
688091
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Xdtmwgxvrn | Lfkhp | $78.4 Bil | |
ZTS
| Zoetis Inc Class A | Tvsdlmpvlt | Vxrn | $77.9 Bil | |
HLN
| Haleon PLC ADR | Tdrysxhm | Jjfr | $37.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Vzhwjjrp | Scc | $18.8 Bil | |
VTRS
| Viatris Inc | Ghymqlpn | Jrdtw | $12.5 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Vmsjvyy | Jksdx | $12.0 Bil | |
CTLT
| Catalent Inc | Wxcwkpnqx | Mkfsmg | $9.7 Bil | |
PRGO
| Perrigo Co PLC | Mhtkcfx | Brlt | $3.8 Bil | |
CURLF
| Curaleaf Holdings Inc | Lvbyxbpq | Fhkh | $3.4 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Hvqjmvsr | Zxggvl | $3.2 Bil |